NASDAQ Oncology Market News

Invuity Announces Proposed Public Offering of Common Stock

SAN FRANCISCO, July 27, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the ...

Syndax Appoints Leading Experts to Scientific Advisory Board (SAB)

WALTHAM, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical ...

Loxo Oncology to Announce Second Quarter 2016 Financial Results

STAMFORD, Conn., July 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

Pernix Therapeutics Announces Reorganization of Senior Management Team

John Sedor Appointed CEO on a Permanent Basis Company Names Pharmaceutical Industry Veteran, Dr. ...

Merit Medical Announces Appointment of New Director

SOUTH JORDAN, Utah, July 26, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), ...

VBL Therapeutics to Report Second Quarter 2016 Financial Results on August 15

TEL AVIV, Israel, July 26, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

Inovio Pharmaceuticals to Report Second Quarter 2016 Financial Results August 8, 2016

PLYMOUTH MEETING, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

RedHill Biopharma Reports 2016 Second Quarter Financial Results

RedHill maintains a strong and debt-free balance sheet with $47.7 million in cash at ...

Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th

REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th

REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...